Anna Shvygin, Qin Zhou, Carol Aghajanian, Dennis S. Chi, Alexia Iasonos, Roisin Eilish O'Cearbhaill, Aaron Praiss, Britta Weigelt, Rachel N. Grisham. "Treatment duration with avutometinib/defactinib in recurrent low-grade serous ovarian carcinoma by KRAS mutation status.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5561